Human recombinant soluble ACE2 (hrs ACE2) shows promise for treating severe COVID19
Suitable candidate Adults seeking nad+ iv therapy for fatigue, brain fog, anti-aging support Patients in good general health with realistic expectations Patients who can attend a doctor-led consultation before treatment Not suitable for Pregnancy or breastfeeding Active skin infection or open wound in the treatment area Recent sunburn or active dermatitis Known allergy to any product used during the treatment Certain medical conditions or medications disclosed at consultation Risks & side effects Every medical procedure carries some risk
The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 6-hydroxydopamine (6-OHDA), and 5-S-cysteinyl-dopamine (CysDA) models each target dopaminergic neurons and increase oxidative damage to the brain, providing valuable insight to the efficacy of mitigating oxidative stress as a mechanism of sulforaphanes neuroprotective effects
They will also assist you in digesting food so you can start using it for energy and stop worrying about unnecessary weight gain
Abstract Clinical and pre-clinical evidence demonstrates that adolescent -9-tetrahydrocannabinol (THC) exposure, the primary psychoactive component of cannabis, increases the risk of developing neuropsychiatric symptoms in later life
#FunctionalMedicine #HormoneHealth #PatientEducation To view or add a comment, sign in EGCG: Redefining Metabolic Health Beyond the Bathroom ScaleWeight loss is just the headline
